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ABSTRACT
Background: Goals of treating childhood severe acute malnutri-
tion (SAM), in addition to anthropometric recovery and preventing
short-term mortality, include reducing the risks of subsequent seri-
ous infections. How quickly and how much the risk of serious illness
changes during rehabilitation are unknown but could inform improv-
ing the design and scope of interventions.
Objective: The aim of this study was to investigate changes in the
risk of life-threatening events (LTEs) in relation to anthropometric
recovery from SAM.
Design: This was a secondary analysis of a clinical trial including
1778 HIV-uninfected Kenyan children aged 2–59 mo with compli-
cated SAM, enrolled after the inpatient stabilization phase of treat-
ment, and followed for 12 mo. The main outcome was LTEs, defined
as infections requiring rehospitalization or causing death. We exam-
ined anthropometric variables measured at months 1, 3, and 6 after
enrollment in relation to LTEs occurring during the 6 mo after each
of these time points.
Results: Over 12 mo, there were 823 LTEs (257 fatal), predom-
inantly severe pneumonia and diarrhea. At months 1, 3, and 6,
557 (34%), 764 (49%), and 842 (56%) children had a weight-for-
height or -length z score (WHZ) ≥−2, respectively, which, com-
pared with a WHZ <−3, was associated with lower risks of subse-
quent LTEs [adjusted HRs (95% CIs): 0.50 (0.40, 0.64), 0.30 (0.23,
0.39), and 0.23 (0.16, 0.32), respectively]. However, children with a
WHZ ≥−2 at 1, 3, and 6 mo still had 39 (95% CI: 32, 47), 26 (95%
CI: 22, 32), and 15 (95% CI: 12, 20) LTEs/100 child-years of obser-
vation during the following 6mo.WHZ at study enrollment predicted
subsequent WHZ but not the risk of LTEs. Changes in height-for-age
z score did not predict LTEs.
Conclusions: Anthropometric response was associated with a rapid
and substantial reduction in risk of LTEs. However, reduction in
susceptibility lagged behind anthropometric improvement. Disease
events, together with anthropometric assessment, may provide a
clearer picture of the effectiveness of interventions. Robust proto-
cols for detecting and treating poor anthropometric recovery and
addressing broader vulnerabilities that complicated SAM indicates
may save lives. This trial was registered at www.clinicaltrials.gov as
NCT00934492. Am J Clin Nutr 2018;107:626–634.
Keywords: malnutrition, SAM, children, recovery, life-threatening
infections, mortality
INTRODUCTION
Severe acute malnutrition (SAM) affects ≥16 million children
aged<5 y,∼1million of whom die annually, predominantly from
common infections (1–3). Pooled global data suggest that the risk
of death from all causes, diarrhea, or pneumonia among children
in the community with SAM is ∼9-, 13-, and 8-fold higher than
among well-nourished children, respectively (1, 4).
The treatment of SAM involves treating infections, therapeu-
tic feeding, correcting metabolic and electrolyte imbalances, and
psychosocial support to prevent short-term mortality and achieve
catch-up growth (5). SAM with infectious complications is usu-
ally treated in the hospital, although children with uncomplicated
SAM are treated as outpatients.
Important longer-term goals of the treatment of SAM, in addi-
tion to anthropometric recovery, are reducing the susceptibility to
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life-threatening infections, restoring a healthy body composition,
and improving neurocognitive status (5). However, severe illness
and mortality are well recognized as occurring after treatment of
SAM or moderate acute malnutrition (6–9). It is conceivable that
anthropometric recovery and reduced susceptibility to infection
may exhibit different temporal patterns, and thus simple anthro-
pometric measurements might not directly reflect immediate risk.
Although several studies have examined pediatric postdischarge
mortality in developing countries, to our knowledge no study has
examined the risk and timing of life-threatening illness during
and after recovery from complicated SAM treated in the hospi-
tal in low-resource settings (10). Such knowledge could provide
evidence to inform recommendations for follow-up to reduce the
overall mortality associated with SAM.
We aimed in this study to determine changes in the risk of
life-threatening events (LTEs) in relation to anthropometric sta-
tus during recovery from SAM. We performed a secondary anal-
ysis of data from a randomized controlled trial amongst 1778
HIV-uninfected children admitted to the hospital with compli-
cated SAM, who were treated and closely followed up for new
infectious disease episodes for 1 y.
METHODS
Study design
We performed a secondary observational cohort analysis of
data from a randomized controlled trial investigating the efficacy
of daily cotrimoxazole prophylaxis in reducing long-termmortal-
ity among HIV-uninfected children with SAM admitted to 4 hos-
pitals in Kenya (7). In the parent trial, participants were randomly
assigned to receive daily cotrimoxazole prophylaxis or placebo
for the first 6 mo and followed up for 12 mo, as described else-
where (7). There was no evidence that daily cotrimoxazole pro-
phylaxis reduced mortality or improved growth among this pop-
ulation in the primary trial (7).
Study setting
Children were recruited in the pediatric wards of 3 secondary
hospitals—Kilifi County Hospital (rural), Malindi subcounty
hospital (rural), and the Mbagathi subcounty hospital in Nairobi
(urban)—and 1 tertiary-level hospital, Coast General Hospital in
Mombasa (urban). Inpatient care for SAM and other conditions
and subsequent outpatient care was provided according to WHO
and Kenyan national guidelines (5).
Study population
The parent trial participants were children aged 2–59 mo who
had a negative HIV rapid antibody test and who were admit-
ted to the hospital with SAM, defined as midupper arm circum-
ference (MUAC) <11.0 cm (children aged 2–6 mo) or MUAC
<11.5 cm (children aged 6–59 mo) or the presence of kwash-
iorkor at any age (7). The more traditional method of assess-
ing childhood malnutrition, weight-for-height or -length z score
(WHZ), was not used for trial entry becauseMUAC predicts mor-
tality better thanWHZ (11). HIV-infected children were excluded
from the parent trial because daily cotrimoxazole prophylaxis is
already standard of care for this group. Participants were enrolled
once they had completed the stabilization phase of inpatient care,
as defined by the WHO, and discharged following WHO guide-
lines (5). At hospital discharge, nutritional counseling was given
to caregivers, along with ready-to-use therapeutic food, and fami-
lies were referred to community-basedmanagement of acutemal-
nutrition centers located either at the hospital or in community fa-
cilities, if these were more accessible, to continue with outpatient
therapeutic feeding.
Variables
The primary outcomes of interest were LTEs, defined as in-
fections occurring after discharge from the index hospital admis-
sion requiring rehospitalization or causing death. LTEs were di-
agnosed and recorded by trained study clinicians according to the
WHO 2005 clinical definitions (5).
To determine the associations between anthropometric attain-
ment during follow-up and subsequent LTEs, we examined the
exposures of nutritional status defined byWHZ, absoluteMUAC,
and height- or length-for-age z score (HAZ) after 1, 3, and 6 mo,
and the demographic, clinical, and anthropometric characteristics
at study enrollment.
To maintain uniformity in follow-up time for analysis at each
of these time points and tomaximize the duration analyzed within
the overall 12-mo follow-up period, we identified the LTEs that
occurred during 6 mo after each time point. Thus, the analysis
of anthropometric status at month 1 was in relation to LTEs oc-
curring from months 1 to 7. Similarly, for anthropometric status
at months 3 and 6, LTEs were analyzed from months 3 to 9 and
from months 6 to 12 (the end of trial follow-up), respectively.
Because children were enrolled based on MUAC, they
had a range of WHZ and HAZ values at study enrollment.
We performed the primary analysis using WHZ because its
calculation is age-independent and it is the standard measure of
anthropometric recovery used by the WHO (12, 13). We also ex-
amined absoluteMUAC because this was the enrollment criterion
(in addition to kwashiorkor), and MUAC-only programs are in-
creasingly utilized (7). Kwashiorkor was present in 17% of chil-
dren and included in the study enrollment analysis, but was not
considered a separate factor in the analyses performed at 1, 3,
or 6 mo because it was rarely present at follow-up (1.1%, 0.2%,
and 0.2% at 1, 3, and 6 mo, respectively), and WHZ was treated
as “missing” at these time points if kwashiorkor was present.
We also examined LTEs after a missing WHZ value, because
this may be a source of bias where nonattendance at follow-
up is associated with illness, lack of access, or socioeconomic
disadvantage.
Data sources and measurement
At enrollment, child and caregiver demographic characteris-
tics, immunization status, clinical examination, admission di-
agnoses, chronic conditions, and anthropometric measurements
(weight, height or length, MUAC) were collected. Children’s
weights were measured with the use of an electronic scale (Seca
825), length or height with the use of an infantometer (Seca 416)
or stadiometer (Seca 215), and MUAC with the use of insertion
tape (TALC) (7). We calculated anthropometric z scores at study
enrollment and at 1, 3, and 6 mo with the use of the 2006 WHO
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growth references. Severe anemia was defined as a hemoglobin
concentration <5 g/dL.
The children were followed up at the study clinics monthly for
the first 6 mo, and then bimonthly through month 12. We col-
lected history of any readmission to the 4 study sites hospitals
and any nonstudy hospitals at each visit. In addition, free walk-
in clinics were provided at the study hospitals for unscheduled
visits where minor illnesses were treated on an outpatient basis
or children were referred for hospital admission in case of se-
vere illness. Details of readmissions to hospital or deaths were
recorded directly at the study hospitals, from discharge letters,
from the medical records for admissions to nonstudy hospitals,
or from death certificates. When a child did not attend the study
clinic at the scheduled follow-up, they were traced in the commu-
nity, vital status and history of hospitalizations were sought, and
MUACwasmeasured. In the event of death outside a study hospi-
tal, verbal autopsies were conducted after a culturally appropriate
interval. Causes of death were assigned by 2 independent pedia-
tricians after review of each child’s available information (7).
Study size
Given the fixed nature of study population from the parent trial,
no formal sample size determination for this secondary analysis
was conducted. We used the sample size calculated in the par-
ent trial, which had 90% power to detect a one-third reduction
in mortality, accounting for loss to follow-up, assuming 15% of
children in the control armwould die. A total of 1778 participants
were enrolled into the trial. Overall, there were 823 LTEs among
612 participants.
Study approvals
The trial and secondary analyses were approved by the Kenya
National Ethical Review Committee (SSC 1562) and the Oxford
Tropical Research Ethics Committee (OXTREC reference
18-09). The trial was registered at clinicaltrials.gov
(NCT00934492).
Statistical methods
Statistical analysis was conducted with the use of Stata version
13.1 (StataCorp). We categorized nutritional status after 1, 3, and
6 months as not wasted (WHZ ≥−2), moderately wasted (WHZ:
−3 to−2), and severely wasted (WHZ<−3; reference category).
We also examined absolute MUACs of ≥12.5, 11.5–12.4, and
<11.5 cm and HAZs ≥−2, −3 to −2.01, and <−3. Where cat-
egorical WHZ, MUAC, and HAZ were used in the analysis, an
extra group was assigned to denote the missing anthropometric
data. Imputation was not performed because children with miss-
ing data (e.g., a missed follow-up visit) were anticipated to have
a poorer outcome.
The intervention tested in the parent trial was unsuccessful in
influencing either mortality or nutritional recovery (7). However,
to control for any nonsignificant effects, while including all avail-
able children, all of the analyses were adjusted for study group
allocation.
We performed a multiple events survival analysis, allowing
participants to contribute>1 LTE during the entire 12-mo follow-
up, then during the 6-mo periods after the follow-up visits at
months 1, 3, and 6. Data were censored at 182 d after each of these
visits or at death or loss to follow-up. Incidence rates of LTEs
were computed as the number of episodes per child-year of obser-
vation (CYO). Observation time was split by using Lexis expan-
sion, and changes in the monthly incidence rate of LTEs during
follow-up were tested with the use of an extension of Wilcoxon’s
rank-sum test for trend across ordered groups (14).
To examine the effect of nutritional recovery after 1, 3, and
6 mo on the subsequent risk of LTEs during the next 6 mo, we
constructed Kaplan-Meier survival plots and used Cox propor-
tional regression to compute HRs, adjusting for study enrollment
age, sex, recruitment site, and randomization arm. We computed
the HRs for all LTEs, fatal episodes, severe pneumonia, severe di-
arrhea, and “other” LTEs. To test time lag in recovery, we tested
the hypothesis that the HR-associated continuousWHZswere not
heterogeneous at months 1, 3, and 6 with the use of meta-analysis
with random effects.
We usedmultinomial logistic regression to analyze the putative
study enrollment risk factors for nutritional status (not wasted,
moderately wasted, and severely wasted) at months 1, 3, and 6
(15, 16). All of the independent variables hypothesized a pri-
ori to be potentially important (age, sex, nutritional status, size
at birth, primary caregiver other than the child’s mother, eco-
nomic indicators, and clinical presentation at index admission),
as well as enrollment site (a stratification in the parent trial) and
study group allocation, were examined in the univariate multi-
nomial logistic regression analysis and retained in the multivari-
able regression models. We tested for linear trend across the 3
ordered nutritional groups (WHZ: ≥−2, −3 to −2, and <−3)
using linear regression with stepwise elimination of independent
variables at P values ≥0.1, and reported variables with a final
P value <0.05.
RESULTS
Study participants
A total of 1778 participants were recruited to the parent trial:
300 (17%) had edema, 908 (51%) had a WHZ <−3, 373 (21%)
had a WHZ of −3 to −2, and 197 (11%) had a WHZ ≥−2. A to-
tal of 1716 children were discharged and followed up in the com-
munity (Figure 1). At months 1, 3, and 6, 1654, 1569, and 1510
children were in follow-up, respectively (Figure 1). By the end of
follow-up (month 12), 1429 (80%) were in follow-up, 257 (14%)
had died, and 92 (5.1%) were either lost to follow-up or voluntar-
ily withdrew from the study (Figure 1). There was no difference
in enrollment characteristics between childrenwho completed the
study as planned and those lost to follow-up (all P> 0.05). Study
enrollment characteristics stratified byWHZ category at 3 mo are
shown in Table 1.
Anthropometric recovery
At months 1, 3, 6, and 12, WHZs <−3 were present in 551
(34%), 308 (20%), 204 (13%), and 124 (8.6%) children, respec-
tively. At these time points, 557 (34%), 764 (49%), 842 (56%),
and 930 (65%) of children had WHZs ≥−2 (Supplemental
Table 1). The mean ± SD WHZ, MUAC, and HAZ at the final
follow-up at month 12 were −1.16 ± 1.4, 13.5 ± 1.4 cm, and
−2.88 ± 1.4, respectively.
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FIGURE 1 Study flow chart showing numbers of included participants during follow-up at the analysis time points. WHZ, weight-for-height or -length
z score.
Children who had a WHZ ≥−2 at 1 mo had a 90% probability
of sustaining this at 3 and 6 mo. However, for children with a
WHZ <−3 at 1 mo, only 24% and 37% had a WHZ ≥−2 by 3
and 6 mo, respectively.
All LTEs during 12 mo of follow-up
After enrollment, there were 823 LTEs (257 deaths and 566
nonfatal events) among 612 of 1778 (34%) participants during
1556 CYOs during the 12-mo follow-up [incidence rate: 0.54
(95% CI: 0.51, 0.58)/CYO] (Supplemental Table 2). Of the 823
LTEs, 282 (34%) occurred either in a nonstudy hospital or in the
community.
There were 413, 207, and 274 episodes of severe pneumonia,
diarrhea, and other LTEs [incidence rates (95% CIs): 0.21 (0.19,
0.23), 0.10 (0.09, 0.12), and 0.10 (0.08, 0.12) episodes per CYO,
respectively]. The 274 episodes of other LTEs were as follows:
53 tuberculosis, 42 urinary tract infections, 21 malaria, 18 severe
anemia, 27 sepsis, 15 meningitis, 4 bacteremia, 52 unknown se-
vere febrile illness, and 42 causes of death unknown. The inci-
dence of all LTEs declined during follow-up (all P-trend< 0.005;
Figure 2, Supplemental Table 2).
Association between nutritional status during follow-up and
risk of LTEs
A total of 602 of 823 (73%) of all LTEs occurred after month
1 (Supplemental Table 3). The adjusted HRs (aHRs) for LTEs
during the 6 mo after the follow-up visits at 1, 3, and 6 mo in-
dicated a reduction in risk by 34%, 62%, and 73%, respectively,
for children with WHZs of −3 to −2 and 50%, 70%, and 77%,
respectively, for children with WHZs ≥−2, compared with those
with WHZs <−3 at each visit (Table 2, Figure 3).
MUAC categories were associated with protective associa-
tions similar to WHZ during follow-up (Table 2, Supplemental
Figure 1). However, there was no reduction in the risk of LTEs as-
sociatedwithHAZ categories at these time points (Supplemental
Table 4, Supplemental Figure 2). The HRs for specific LTEs are
shown in Table 2.
To further investigate a potential time lag in the effect of nutri-
tional recovery on the susceptibility to LTEs, the aHRs associated
with continuous WHZ was compared between months 1, 3, and
6. At months 3 and 6, aHRs per unit of WHZ were lower than at
month 1 (P< 0.003) (Supplemental Table 5). There was no evi-
dence that the aHRs per unit of HAZ differed between months
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TABLE 1
Characteristics of the study participants at study enrollment by nutritional status at month 31
Nutritional status at 3 mo of follow-up: WHZ
Characteristic ≥−2 (n = 764) −3 to −2 (n = 306) <−3 (n = 308) P2
Female sex, n (%) 394 (52) 142 (46) 128 (42)
Age,3 mo 12.0 (7.5, 18.3) 11.2 (7.8, 16.2) 9.9 (6.9, 14.3) 0.03
Nutritional edema, n (%) 187 (25) 32 (10) 18 (5.9)
Midupper arm circumference, cm 10.7 ± 1.14 10.5 ± 0.9 10.3 ± 0.9
Weight-for-length z score −2.9 ± 1.2 −3.6 ± 1.0 −4.1 ± 1.1 <0.001
Length-for-age z score −2.9 ± 1.6 −2.7 ± 1.5 −2.7 ± 1.7
Hemoglobin, g/dL 9.7 ± 2.2 9.9 ± 2.5 10.1 ± 2.2
Clinical signs of rickets, n (%) 67 (8.8) 55 (18) 61 (20) 0.003
Known tuberculosis at enrollment, n (%) 33 (4.3) 14 (4.6) 6 (2.0)
Index admission for severe pneumonia n (%) 234 (31) 117 (38) 143 (47) 0.03
Index admission for diarrhea, n (%) 448 (59) 172 (56) 166 (54) <0.001
Received conjugate pneumococcal vaccine,5 n (%) 435 (57) 181 (59) 181 (59)
Born premature/underweight,6 n (%) 165 (22) 65 (21) 67 (22)
Randomly assigned to cotrimoxazole prophylaxis, n (%) 396 (52) 153 (50) 147 (48)
Urban sites, n (%) 536 (70) 237 (77) 268 (88)
Mother as primary caretaker, n (%) 699 (92) 292 (95) 292 (96) 0.02
Primary caretaker had at least primary education,7 n (%) 445 (58) 183 (59) 179 (59)
Primary caretaker aged <25 y,7 n (%) 221 (29) 68 (22) 71 (23)
Household with ≥5 persons, n (%) 459 (60) 181 (59) 158 (52)
Using solid fuel indoors, n (%) 393 (55) 121 (43) 121 (44)
House wall material of mud/iron sheet, n (%) 397 (52) 144 (47) 104 (34)
Water source, nontap, n (%) 213 (28) 72 (23) 79 (26)
Type of toilet: community shared/none, n (%) 693 (91) 265 (86) 275 (90)
1Weight-for-length z score excludes children with kwashiorkor. WHZ, weight-for-height or -length z score.
2Linear trend P values derived by using stepwise linear regression analysis; variables with P ≥ 0.1 were eliminated and those with a final P < 0.05 are
reported.
3Values are medians (IQRs).
4Mean ± SD (all such values).
5≥1 dose of conjugate pneumococcal vaccine at enrollment.
6Gestational age of <37 wk or birth weight <2500 g.
7Data collected from April 2011.
1, 3, and 6 (P = 0.77) (Supplemental Table 5, Supplemental
Figure 2).
WHZ at enrollment, but not age, sex, size at birth, index admis-
sion diagnosis, rural or urban site, and all other variables exam-
ined, was associated with WHZ category after 1, 3, 6, and 12 mo
(Supplemental Tables 6–9). However, neither WHZ nor HAZ
at enrollment were associated with subsequent LTEs during the
following 6 or 12mo (Figure 3A, Supplemental Table 4, and Sup-
plemental Figure 2A), and WHZ at intermediate months did not
alter the effects ofWHZmeasured at 1, 3, and 6mo on subsequent
LTEs (Supplemental Table 10).
Association between nutritional status during follow-up and
case fatality of LTEs
The overall case fatality ratio for LTEs was 257/823 (31%;
95% CI: 28%, 34%) and did not significantly change over time
(P = 0.22). Children with a WHZ <−3 consistently had higher
case fatality ratios for LTEs, which also did not change with time
(P = 0.86; Supplemental Table 3).
DISCUSSION
After treatment for complicated SAM in the absence ofHIV in-
fection, higher WHZ or MUAC during follow-up was associated
with a strikingly lower risk of subsequent LTEs. Not surprisingly,
the major factor at enrollment that was associated with WHZ at
follow-up was WHZ at enrollment, but importantly, in this group
initially selected by MUAC, WHZ at enrollment was not associ-
ated with the risk of LTEs, indicating that a child’s capacity to
respond to treatment is key to risk reduction.
Compared with being severely wasted, there were relatively
small differences in risk between becoming moderately wasted
and becoming nonwasted, suggesting that some WHZ recovery
is a highly worthwhile target. The association between anthro-
pometric measures during recovery and serious illness could be
operating in either direction: it is plausible that illness episodes
limited nutritional recovery through anorexia and diversion and
losses of nutrients (17, 18). On the other hand, those remaining
wasted may have had an increased risk of infection compared
with those who partially or fully recovered.
The 15 LTEs/100 CYOs among children not classified as
wasted by WHZ 6 mo after hospitalization that we observed is a
far higher number than the incidence of hospitalization reported
in other contexts in Africa. Among Tanzanian infants, the in-
cidence of hospital admission within the first year of life was
4.32/100 CYOs in rural and 3.72/100 CYOs in urban (19) set-
tings. In Bamako, Mali, 5.3 children/100 CYOs were hospital-
ized during the first year of life and 0.64/100 CYOs between
ages 1 and 5 y (20). The incidence we observed is also higher
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TABLE 2
HRs for LTEs occurring in the subsequent 6 mo by WHZ and absolute MUAC by type of LTE at months 1, 3, and 6 of follow-up1
WHZ (95% CI) MUAC (95% CI)
≥−2 −2 to −3 Missing <−3 ≥12.5 cm 12.5–11.5 cm Missing <11.5 cm
At month 1
All LTEs 0.50 (0.40, 0.64) 0.66 (0.52, 0.84) 0.67 (0.45, 0.99) 1.0 0.37 (0.25, 0.55) 0.59 (0.47, 0.75) 0.88 (0.58, 1.33) 1.0
Death 0.39 (0.24, 0.65) 0.39 (0.22, 0.68) 1.47 (0.86, 2.50) 1.0 0.18 (0.05, 0.59) 0.44 (0.26, 0.75) 2.15 (1.23, 3.77) 1.0
Severe pneumonia 0.51 (0.37, 0.71) 0.63 (0.45, 0.88) 0.37 (019, 0.73) 1.0 0.30 (0.16, 0.59) 0.66 (0.49, 0.91) 0.47 (0.22, 1.01) 1.0
Severe diarrhea 0.33 (0.19, 0.58) 0.78 (0.49, 1.22) 0.43 (0.17, 1.08) 1.0 0.62 (0.26, 1.50) 0.91 (0.58, 1.43) 0.48 (0.15, 1.53) 1.0
Others2 0.36 (0.24, 0.56) 0.44 (0.28, 0.69) 0.95 (0.55, 1.64) 1.0 0.29 (0.14, 0.59) 0.48 (0.31, 0.73) 1.50 (0.85, 2.64) 1.0
At month 3
All LTEs 0.30 (0.23, 0.39) 0.38 (0.28, 0.53) 0.45 (0.31, 0.65) 1.0 0.30 (0.22, 0.40) 0.40 (0.30, 0.53) 0.55 (0.37, 0.82) 1.0
Death 0.16 (0.09, 0.31) 0.32 (0.16, 0.64) 0.70 (0.37, 1.33) 1.0 0.21 (0.10, 0.43) 0.35 (0.19, 0.65) 1.06 (0.56, 2.03) 1.0
Severe pneumonia 0.30 (0.20, 0.43) 0.38 (0.24, 0.60) 0.31 (0.17,0.57) 1.0 0.29 (0.19, 0.44) 0.46 (0.31, 0.67) 0.35 (0.18, 0.67) 1.0
Severe diarrhea 0.29 (0.17, 0.49) 0.53 (0.30, 0.94) 0.09 (0.02, 0.39) 1.0 0.28 (0.15, 0.51) 0.31 (0.18, 0.55) 0.12 (0.03, 0.49) 1.0
Others2 0.32 (0.20, 0.51) 0.33 (0.18, 0.60) 0.54 (0.29, 1.01) 1.0 0.25 (0.14, 0.44) 0.48 (0.30, 0.78) 0.81 (0.44, 1.49) 1.0
At month 6
All LTEs 0.23 (0.16, 0.32) 0.41 (0.27, 0.62) 0.46 (0.27, 0.62) 1.0 0.30 (0.21, 0.44) 0.45 (0.31, 0.67) 0.46 (0.28, 0.75) 1.0
Death 0.11 (0.05, 0.26) 0.44 (0.20, 0.97) 0.69 (0.32, 1.49) 1.0 0.17 (0.07, 0.40) 0.51 (0.24, 1.10) 0.87 (0.38, 1.99) 1.0
Severe pneumonia 0.18 (0.10, 0.30) 0.33 (0.18, 0.61) 0.24 (0.11, 0.52) 1.0 0.26 (0.15, 0.44) 0.32 (0.17, 0.59) 0.28 (0.12, 0.64) 1.0
Severe diarrhea 0.24 (0.12, 0.48) 0.41 (0.18, 0.90) 0.25 (0.08, 0.74) 1.0 0.33 (0.16, 0.69) 0.54 (0.25, 1.18) 0.35 (0.11, 1.07) 1.0
Others2 0.15 (0.08, 0.28) 0.30 (0.14, 0.62) 0.58 (0.30, 1.11) 1.0 0.21 (0.11, 0.41) 0.56 (0.29, 1.06) 0.62 (0.29, 1.33) 1.0
1Values are adjusted HRs (95% CIs). WHZ andMUAC values were adjusted for age, sex, recruitment site, and randomization group. LTE, life-threatening
event; MUAC, midupper arm circumference; WHZ, weight-for-height or -length z score.
2“Others” included 4 cases of bacteremia, 15 cases of meningitis, 42 urinary tract infections, 21 cases of malaria, 53 cases of tuberculosis, 27 cases of
sepsis, 18 cases of severe anemia, 52 cases of unknown febrile illness, and 42 unknown causes of death in community.
than among Zambian children with HIV infection being treated
with antiretroviral therapy and cotrimoxazole prophylaxis (8 hos-
pital admissions/100 CYOs during 12 mo of follow-up) (21, 22).
Thus, children with complicated SAM remain highly susceptible
to life-threatening illness despite nutritional recovery. This could
be due to ongoing immunologic dysfunction, untreated or par-
tially treated infections such as tuberculosis or bacterial infec-
tions with reduced sensitivity to antimicrobials, other illnesses,
poverty, or other unfavorable household- and community-level
exposures.
The increased reduction in risk of LTEs per unit of WHZ from
month 1 to month 6 (Supplemental Table 5) shows a time lag
in recovery from susceptibility after treatment. Very few stud-
ies have investigated the dynamics of illness episodes or physio-
logic and immunologic recovery after treatment of malnutrition.
In Brazil, during treatment for SAM following WHO guidelines,
phagocytic function improved, but lymphocyte counts and the
production of free radicals remained lower than in well-nourished
controls (23). Malnourished children typically have thinning of
the intestinal mucosa, shorter villi, loss of goblet cells, infiltra-
tion of lymphocytes, and both intestinal and systemic inflamma-
tion and are vulnerable to bacterial translocation (24–26). How-
ever, Chilean children recovering from SAM retained histologic
evidence of damaged intestinal mucosa, although there was im-
provement shown by electron microscopy of the intestinal brush
border (27). There is also evidence that the intestinal microbiome
is important in the susceptibility to, and recovery from, malnutri-
tion (28). Components of the microbiome are key to nutrient pro-
cessing and also influence programming of the immune system.
In Uganda, circulating leptin, a marker of white adipose tissue
that is associated with energy production during infection and
long-term mortality, did not change significantly after hospital
discharge (29). These studies, although limited, suggest longer-
term effects of malnutrition itself, as well as nutrition and care
provision at home or living conditions.
In our study, after 6 mo of follow-up, only 56% children were
not classified as wasted by a WHZ <−2. This was similar to
the overall proportion of nutritionally “cured” children among
those hospitalized with SAM in Malawi (including both compli-
cated and uncomplicated cases by current definitions); however,
this proportion ranged between 37% among HIV-infected chil-
dren and 71% among non–HIV-infected children (30). In con-
trast, children with uncomplicated SAM treated in the commu-
nity before the onset of serious illness typically have much higher
recovery rates, with an estimated pooled proportion recovered
of 88% (31). We were not able to ascertain adherence to ready-
to-use therapeutic foods after hospital discharge; low adherence
could partly explain the low recovery in this study.
Notably, children who missed some follow-up visits had ele-
vated mortality risks, suggesting that data were not “missing at
random” and were important to include in mortality estimates.
This is likely to relate to illness, social or family problems, or
reduced access to, or engagement with, medical services.
Our results raise the hypotheses that mortality after compli-
cated SAM could be reduced by specific interventions to detect,
investigate, and manage children with a suboptimal anthropomet-
ric response and that a broader set of vulnerabilities are indicated
by an episode of complicated SAM that will need to be tackled
to reduce the overall mortality associated with this condition.
Strengths and limitations
The context of a randomized controlled trial is both a strength
and a limitation. The major strengths of this study are rigorous
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FIGURE 2 Monthly incidence rates (95% CIs) of any life-threatening event (A), severe pneumonia (B), diarrhea (C), and other life-threatening episodes
(D). cyo, child-year of observation.
follow-up, very low drop out (5%), well-documented episodes of
LTEs, monthly anthropometric measurements, and a large sample
size.
However, following up children in a clinical trial could have
led to either over- or underreporting of LTEs. The free clinical ser-
vices offered to participants could have led tomore children being
examined by the study clinicians and hospitalized. On the other
hand, the availability of early treatment for mild episodes may
have prevented more serious disease episodes. Defining com-
mon life-threatening infections with the use of the WHO clini-
cal criteria, which are sensitive rather than specific, could have
included noncases or excluded some cases (32). Use of data as-
signed by standardized verbal autopsy for community deaths, and
from medical records when LTEs or deaths occurred in nonstudy
hospitals. LTEs occurring in nonstudy hospitals could have af-
fected the final diagnosis assigned, although not the fact that an
LTE occurred.
Another possible limitation of the study is that we did not know
the children’s nutritional and immunologic status before the index
hospitalization or changes in household exposures during recov-
ery, which would have influenced the child’s susceptibility, nu-
tritional recovery, and long-term survival (33). Our results could
also have been affected by survival bias. Excluding children with
HIV means that we cannot generalize study results to children
with SAM and HIV, a common feature in Africa, with known el-
evated mortality risk (6).
Future research is needed to better characterize anthropo-
metric recovery in relation to immunologic and physiologic
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FIGURE 3 Kaplan-Meier graphs of the probabilities of remaining free of LTEs in the subsequent 6 mo by WHZ (colored areas represent 95% CIs) after
study enrollment (A), month 1 (B), month 3 (C), and month 6 (D). WHZ: <−3 (red); −2 to −3 (blue), and ≥−2 (green). LTE, life-threatening event; WHZ,
weight-for-height or -length z score.
mechanisms of extended susceptibility to life-threatening dis-
ease, and in relation to longer term health outcomes (34). The
role of nonnutritional factors needs further exploration, includ-
ing undiagnosed infection, nosocomial acquisition of resistant
pathogens, underlying chronic noninfectious conditions, and the
social environment.
Conclusions
Better nutritional status during recovery was associated with a
rapid and substantial reduction in risk of LTEs. However, the re-
duction in susceptibility lagged behind anthropometric recovery
and children who had “recovered” still had much higher risks
than the general community. Research should ultimately guide
evidence-based identification and intervention for children who
respond poorly to treatment, because they are the most likely to
become seriously ill or die. Monitoring disease episodes, together
with anthropometric changes, may provide a more comprehen-
sive picture of the true efficacy of nutrition-specific and allied
interventions.
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